Biocept Inc. (BIOCQ)
OTCMKTS: BIOCQ · Delayed Price · USD
0.0001
0.00 (0.00%)
Apr 18, 2024, 11:35 AM EDT - Market closed
Biocept Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.86 | 61.25 | 27.46 | 5.53 | 3.25 | 5.07 | 3.22 | 0.61 | 0.13 | 0.13 | Upgrade
|
| Revenue Growth (YoY) | -57.78% | 123.04% | 396.71% | 70.09% | -35.87% | 57.26% | 428.46% | 357.15% | -0.62% | 22.83% | Upgrade
|
| Cost of Revenue | 28.44 | 37.76 | 21.34 | 10.98 | 10.05 | 9.35 | 6.92 | 4.6 | 2.17 | 2.33 | Upgrade
|
| Gross Profit | -2.58 | 23.49 | 6.12 | -5.45 | -6.8 | -4.28 | -3.7 | -3.99 | -2.04 | -2.2 | Upgrade
|
| Selling, General & Admin | 23.24 | 20.93 | 16.37 | 12.91 | 12.99 | 13.53 | 11.61 | 9.57 | 7.34 | 2.66 | Upgrade
|
| Research & Development | 6.16 | 4.96 | 5.22 | 4.7 | 4.47 | 3.36 | 2.71 | 2.86 | 4.5 | 3.09 | Upgrade
|
| Operating Expenses | 29.4 | 25.89 | 21.59 | 17.61 | 17.46 | 16.9 | 14.33 | 12.42 | 11.84 | 5.75 | Upgrade
|
| Operating Income | -31.98 | -2.41 | -15.47 | -23.06 | -24.26 | -21.17 | -18.03 | -16.41 | -13.87 | -7.94 | Upgrade
|
| Interest Expense / Income | 0.32 | 0.29 | 0.24 | 0.25 | 0.31 | 0.48 | 0.53 | 0.64 | 1.79 | 2.07 | Upgrade
|
| Other Expense / Income | -0.09 | - | 2.1 | 1.83 | - | -0.05 | -0.15 | -0.1 | 0.2 | -0.78 | Upgrade
|
| Pretax Income | -32.21 | -2.7 | -17.81 | -25.14 | -24.57 | -21.61 | -18.4 | -16.95 | -15.86 | -9.23 | Upgrade
|
| Income Tax | -0.13 | 0.13 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Net Income | -32.09 | -2.82 | -17.81 | -25.14 | -24.57 | -21.61 | -18.4 | -16.95 | -15.87 | -9.23 | Upgrade
|
| Preferred Dividends | 0 | 0 | 0 | 0.12 | 0.64 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Net Income Common | -32.09 | -2.82 | -17.81 | -25.26 | -25.21 | -21.61 | -18.4 | -16.95 | -15.87 | -9.23 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change | 14.74% | 24.74% | 473.32% | 638.38% | 205.30% | 187.12% | 73.57% | 314.19% | 2014.29% | 16.67% | Upgrade
|
| EPS (Basic) | -56.70 | -5.70 | -45.00 | -366.90 | -2703.00 | -7074.01 | -17289.02 | -27630.06 | -107190.21 | -1371602.74 | Upgrade
|
| EPS (Diluted) | -56.70 | -5.70 | -45.00 | -366.90 | -2703.00 | -7074.01 | -17289.02 | -27630.06 | -107190.21 | -1371602.74 | Upgrade
|
| Free Cash Flow | -14.1 | 2.12 | -20.65 | -23.78 | -22.5 | -21.05 | -16.15 | -15.32 | -14.97 | -6.2 | Upgrade
|
| Free Cash Flow Per Share | -24.94 | 4.30 | -52.31 | -345.36 | -2412.28 | -6889.90 | -15173.53 | -25010.08 | -101107.46 | -921431.07 | Upgrade
|
| Gross Margin | -9.99% | 38.34% | 22.30% | -98.56% | -209.26% | -84.37% | -114.70% | -653.58% | -1526.91% | -1635.56% | Upgrade
|
| Operating Margin | -123.69% | -3.93% | -56.33% | -417.05% | -746.35% | -417.76% | -559.25% | -2690.70% | -10399.07% | -5917.86% | Upgrade
|
| Profit Margin | -124.09% | -4.61% | -64.86% | -456.89% | -775.56% | -426.42% | -570.86% | -2779.03% | -11892.25% | -6877.86% | Upgrade
|
| Free Cash Flow Margin | -54.51% | 3.46% | -75.21% | -430.21% | -692.26% | -415.31% | -501.02% | -2511.85% | -11221.06% | -4620.71% | Upgrade
|
| EBITDA | -29.7 | 0.23 | -16.57 | -24.11 | -23.46 | -20.55 | -17.55 | -16.05 | -13.82 | -6.9 | Upgrade
|
| EBITDA Margin | -114.86% | 0.37% | -60.34% | -436.18% | -721.71% | -405.39% | -544.49% | -2631.04% | -10361.40% | -5136.70% | Upgrade
|
| Depreciation & Amortization | 2.2 | 2.64 | 1 | 0.77 | 0.8 | 0.58 | 0.32 | 0.26 | 0.25 | 0.27 | Upgrade
|
| EBIT | -31.9 | -2.41 | -17.57 | -24.89 | -24.26 | -21.12 | -17.87 | -16.31 | -14.07 | -7.16 | Upgrade
|
| EBIT Margin | -123.35% | -3.93% | -63.99% | -450.17% | -746.35% | -416.75% | -554.48% | -2673.90% | -10549.68% | -5335.26% | Upgrade
|